| pre Mean(SD) | post treatment Mean(SD) | F value | effect size partial Eta 2 | d |
---|---|---|---|---|---|
ITT(N = 43) | Â | Â | Â | Â | Â |
GAF | 59.49(6.10) | 65.51(6.68) | 40.06*** | 0.33 | 0.94 |
SF-36 PCS | 41.00(11.12) | 46.78(10.22) | 16.31*** | 0.16 | 0.54 |
   Physical functioning | 76.33(17.38) | 84.77(15.92) | 16.49*** | 0.17 | 0.51 |
   Role physical | 27.33(42.19) | 58.14(42.86) | 5.14* | 0.06 | 0.72 |
   Bodily pain | 61.58(25.68) | 68.45(26.94) | 4.08* | 0.05 | 0.26 |
   General health | 38.66(15.76) | 48.74(20.36) | 5.73* | 0.07 | 0.00 |
SF-36 MCS | 25.77 (8.70) | 33.52(10.97) | 25.17*** | 0.23 | 0.78 |
   Vitality | 24.65(13.69) | 39.65(19.32) | 11.58** | 0.12 | 0.90 |
   Social functioning | 43.84(20.79) | 59.59(23.75) | 16.15*** | 0.16 | 0.71 |
   Role emotional | 11.63(28.06) | 34.88(39.14) | 19.06*** | 0.19 | 0.68 |
   Mental health | 37.86(15.82) | 52.09(18.34) | 30.24*** | 0.27 | 0.83 |
Completer (N = 38) | Â | Â | Â | Â | Â |
GAF | 60.18(5.79) | 67.00(5.17) | 41.19*** | 0.53 | 1.24 |
SF-36 PCS | 41.18(11.04) | 47.72(9.62) | 17.73*** | 0.20 | 0.63 |
   Physical functioning | 77.43(16.65) | 86.97(13.78) | 26.38*** | 0.27 | 0.62 |
   Role physical | 23.68(41.08) | 58.55(43.21) | 47.11*** | 0.40 | 0.83 |
   Bodily pain | 62.68(26.63) | 70.46(27.55) | 4.15* | 0.05 | 0.29 |
   General health | 38.62(16.03) | 50.03(20.76) | 13.23** | 0.15 | 0.62 |
SF-36 MCS | 25.93 (8.95) | 34.71(10.90) | 27.53*** | 0.27 | 0.88 |
   Vitality | 24.87(12.81) | 41.84(18.25) | 34.89*** | 0.32 | 1.08 |
   Social functioning | 44.34(21.83) | 62.17(23.87) | 17.21*** | 0.19 | 0.78 |
   Role emotional | 11.40(29.28) | 37.72(40.40) | 20.19*** | 0.22 | 0.75 |
   Mental health | 38.00(16.10) | 54.11(17.93) | 33.73*** | 0.32 | 0.95 |